WHO Database Proposal Seen Benefiting Indian Generics
This article was originally published in PharmAsia News
Executive Summary
Indian drug makers expect to benefit from a portion of an international agreement drafted by the World Health Organization establishing a centralized database of drugs and the countries in which patents have been secured for them. Generics makers see the database as helping to dispel assumptions by some non-governmental organizations that a drug under patent in one country is protected in all nations. The head of the Indian Pharmaceutical Alliance noted that most multinational drug makers seek patents for their products in only 50 to 60 countries. (Click here for more